Tag: Paula Clemens

ReveraGen, Santhera get FDA grant for BMD trial of vamorolone

pallavi123- September 27, 2021

ReveraGen Biopharma and Santhera Pharmaceuticals have secured a $1.2 million grant for funding their clinical trial of vamorolone in Becker muscular dystrophy (BMD) from the ... Read More